Wegovy® is now available as a daily pill.
The first MHRA‑approved GLP‑1 weight‑loss tablet — the same medicine as the Wegovy injection, now needle‑free.
The same medicine — without the needle.
The Wegovy pill is oral semaglutide — the same active ingredient as the Wegovy injection, now in a once‑daily tablet. It’s the first GLP‑1 weight‑loss pill approved by the MHRA, available privately now while the NHS appraisal continues.
A once-daily tablet instead of a weekly injection — ideal if you’d rather avoid needles.
Contains semaglutide — the same active ingredient as the Wegovy injection.
One tablet each morning on an empty stomach — simple to build into your day.
Less appetite, fuller for longer.
Semaglutide mimics GLP‑1, a hormone your gut releases after eating. It reduces appetite and slows how quickly your stomach empties — so you feel full sooner and for longer, and naturally eat less. It works best alongside a reduced‑calorie diet and more physical activity.
Is the Wegovy pill right for you?
The MHRA has licensed the tablet for adults who are:
Living with obesity (a body mass index of 30 or above).
Overweight and living with at least one weight‑related condition — such as high blood pressure, type 2 diabetes, raised cholesterol or sleep apnoea.
Ready to use it alongside a reduced‑calorie diet and increased physical activity.
These medicines aren’t suitable for everyone. Every patient has a clinical assessment with our pharmacist first, and it isn’t prescribed in pregnancy or breastfeeding, or where it isn’t clinically appropriate.
Start low, build up gradually.
You begin on a low dose and step up slowly — at least one month at each level. Building up gradually helps your body adjust and keeps side effects to a minimum.
Already on the weekly 2.4 mg Wegovy injection? The MHRA allows a direct switch to the 25 mg daily tablet — we’ll guide you through it.
One tablet, first thing.
On an empty stomach. Take it in the morning after fasting for at least 8 hours (first thing works well).
Whole, with a sip of water. Swallow the tablet whole with no more than half a glass of water — don’t split, crush or chew it.
Wait 30 minutes. No food, other drinks or other medicines for at least 30 minutes afterwards — eating too soon reduces how well it’s absorbed.
Easy to store. Keep it at room temperature — no fridge needed.
Two ways to take Wegovy.
| Wegovy pill | Wegovy injection | |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| How you take it | Daily tablet | Weekly injection |
| Needles | None | Self‑injected |
| Routine | Empty stomach, wait 30 min | Any time, with or without food |
| Average trial weight loss | ~16.6% (64 wks, OASIS‑4) | ~15% (68 wks, STEP‑1) |
Trial figures come from different studies and aren’t a direct head‑to‑head comparison. Which option suits you best depends on your health, preferences and goals — your pharmacist will help you decide.
Prescribed and monitored, in person.
A GPhC-registered pharmacist assesses you, prescribes if it’s right for you, and supports you through dose changes, side effects and reviews — face to face at your local branch.
Clear pricing, set by your dose.
Your final monthly cost depends on the maintenance dose you settle on, confirmed at your review. Pricing for the 9 mg and 25 mg doses is coming soon. No hidden fees.
Safety: The most common side effects are gastrointestinal (nausea, diarrhoea, constipation) and usually settle. Semaglutide is a prescription‑only medicine — assessed, prescribed and monitored by our pharmacists, and not suitable for everyone.
Common questions.
Is the Wegovy pill available on the NHS?
Not yet. For now it’s a private service. NICE is appraising it for cost‑effectiveness before any NHS use is decided.
Is the pill as effective as the injection?
Both use the same active ingredient (semaglutide) and work the same way. Trial figures come from separate studies, so they aren’t a direct comparison. The best option for you is decided at your assessment.
Can I switch from my weekly injection to the pill?
Yes — the MHRA allows patients on the once‑weekly 2.4 mg injection to move straight to the 25 mg daily tablet. We’ll guide the switch.
Do I still need to diet and exercise?
Yes. The tablet is licensed for use alongside a reduced‑calorie diet and increased physical activity — it supports your effort, it doesn’t replace it.
How do I get started?
Book a quick assessment with our pharmacist. If the treatment is suitable for you, we prescribe, dispense and monitor it from your local MediPill branch.
Is it safe?
It’s a prescription‑only medicine that isn’t suitable for everyone. That’s exactly why every patient is clinically assessed, prescribed and monitored by a GPhC‑registered pharmacist.
See if the Wegovy pill is right for you.
A short, no‑obligation assessment with our pharmacist is all it takes to find out.
Wegovy® is a registered trademark of Novo Nordisk. Wegovy (semaglutide) is a prescription‑only medicine; treatment is subject to a clinical assessment and is not suitable for everyone. Always read the patient information leaflet. Information on this page is for general guidance and is not a substitute for individual medical advice.
